Search Results - "LAVASANI, Farangis"
-
1
Comparison of Effects of Simvastatin Alone Versus Fenofibrate Alone Versus Simvastatin Plus Fenofibrate on Lipoprotein Subparticle Profiles in Diabetic Patients With Mixed Dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen Study)
Published in The American journal of cardiology (15-02-2008)“…Diabetes mellitus is a strong risk factor for atherosclerosis and is often characterized by dyslipidemia. Besides acting on traditional lipids, statins and…”
Get full text
Journal Article -
2
The reduction of inflammatory biomarkers by statin, fibrate, and combination therapy among diabetic patients with mixed dyslipidemia : The DIACOR (Diabetes and Combined Lipid Therapy Regimen) Study
Published in Journal of the American College of Cardiology (18-07-2006)“…The primary objective was to determine the effect of statin-fibrate combination therapy on inflammatory biomarkers in patients with diabetes. Atherosclerosis…”
Get full text
Journal Article -
3
PREDICTION OF FUTURE CARDIOVASCULAR RISK BY ANALYSIS OF VARIOUS CT CORONARY ANGIOGRAPHY-DETERMINED QUANTITATIVE PLAQUE COMPOSITIONAL CHARACTERISTICS AMONG PATIENTS WITH DIABETES ENROLLED IN THE FACTOR-64 STUDY: THE IMPORTANCE OF THE CALCIFIED CORONARY PLAQUE
Published in Journal of the American College of Cardiology (21-03-2017)“…Quantitative compositional coronary plaque and CAC scores were measured using semi-automated software, and their relationship to future MACE (death, myocardial…”
Get full text
Journal Article -
4
Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention
Published in The American heart journal (01-08-2003)“…Diabetes mellitus (DM) is predictive of increased mortality for patients with coronary artery disease (CAD). To what extent this risk extends below the…”
Get full text
Journal Article -
5
-
6
Preoperative use of enoxaparin compared with unfractionated heparin increases the incidence of re-exploration for postoperative bleeding after open-heart surgery in patients who present with an acute coronary syndrome: clinical investigation and reports
Published in Circulation (New York, N.Y.) (24-09-2002)“…Enoxaparin has become an attractive therapy for use during acute coronary syndrome (ACS) because of its potential superior efficacy over unfractionated heparin…”
Get full text
Journal Article -
7
The Reduction of Inflammatory Biomarkers by Statin, Fibrate, and Combination Therapy Among Diabetic Patients With Mixed Dyslipidemia
Published in Journal of the American College of Cardiology (18-07-2006)“…The Reduction of Inflammatory Biomarkers by Statin, Fibrate, and Combination Therapy Among Diabetic Patients With Mixed Dyslipidemia: The DIACOR Study Joseph…”
Get full text
Journal Article -
8
-
9
Preoperative use of enoxaparin compared with unfractionated heparin increases the incidence of re-exploration for postoperative bleeding after open-heart surgery in patients who present with an acute coronary syndrome clinical investigation and reports
Published in Circulation (New York, N.Y.) (2002)Get full text
Journal Article